|06-18-2018 01:00 PM CET - Health & Medicine||
Global Plasmapheresis Market is Expected to Reach US$ 1,500 Mn By 2026-End
Press release from: Fact.MR
Prevalence of autoimmune diseases has led to an upsurge in demand for plasmapheresis globally. Growing need for conducting an extracorporeal therapy is further expected to impact growth of the global autoimmune diseases market positively. Some of the autoimmune diseases that increasingly fuel demand for plasmapheresis include type 1 diabetes, celiac disease, rheumatoid arthritis, temporal arteritis and lupus. In a recently published report, CDC stated that 9.4% of the population in the U.S. have diabetes, and 30.3 million globally. Plasmapheresis is also used for treatment of various forms of neurotherapy and sickle cell diseases.
Request For Sample Report @ www.factmr.com/connectus/sample?flag=S&rep_id=351
According to Fact.MR, the global plasmapheresis market is expected to represent a value of over US$ 1,500 Mn by the end of 2026.
Treatment of the Autoimmune Diseases to Boost Demand
Increasing prevalence of various autoimmune diseases will continue to fuel demand for extracorporeal therapies globally. Occurrence of autoimmune disorders such as lupus can significantly damage various organs such as lungs, kidney, heart, skin and joints. Adoption of plasmapheresis removes putative pathogenic autoantibodies and circulates the immune complexes from the blood of patients with systematic lupus erythematosus. Manufacturers in the healthcare industry are increasingly integrating various technological advancements and innovative features in the plasmapheresis instruments such as apheresis machines in order to offer enhanced instruments for conducting plasmapheresis globally. Bound to these factors, the global plasmapheresis market is expected to witness significant growth during the forecast period.
Research for Biopharmaceutical Applications to Impact Global Market Growth
Demand for plasmapheresis also continues to remain high bound to growing need for donation. Growing need for plasma to treat various disorders such as anaemia, stomach disease, blood loss, cancer, burns, childbirth and heart diseases has led to surge in demand for the donation of the blood products. Moreover, blood products donated are also used for the production of biopharmaceutical medications through the process of fractionation. Biopharmaceutical companies are also increasingly investing in the research and development for production of various medications. Surge in demand for biopharmaceutical medications for the treatment of neuroendocrine tumors, diabetes, cancer and arthritis is further expected to fuel demand for plasmapheresis globally. Moreover, growing need for donating blood products and producing biopharmaceutical products has led to an increasing demand for the plasmapheresis in the global market. Such factors will continue to impact growth of the global plasmapheresis market during positively.
Biopharmaceutical Companies to Represent a Leading Segment
Growing need to conduct plasmapheresis has led to surge in demand for various instruments in the global market. On the basis of product type, the instruments segment is expected to represent the highest revenue growth, accounting for a value of over US$ 260 Mn by the end of 2026. However, the disposables product segment is expected to register a robust CAGR during the forecast period.
Based on end users, the biopharmaceutical companies segment is expected to generate significant revenues, recording for a value of over US$ 100 Mn by the end of 2017. In contrary, the other end users segment is expected to register a significant CAGR through 2026.
By application, the source plasma collection segment is expected to witness a robust revenue growth, accounting for a value of nearly US$ 370 Mn by the end of 2026. On the other hand, the centrifugation application segment is expected to register the highest CAGR throughout the forecast period.
Browse Full Report with TOC @ www.factmr.com/report/351/plasmapheresis-market
Leading market players operating in the global plasmapheresis market include Haemonetics Corporation, Asahi Kasei Kuraray Medical, Terumo Corporation, B Braun Melsungen AG, Baxter Internationalaq IncR4T554RFDD., Fresenius SE & Co. KGaA, Kawasumi Laboratories, Inc. and Kaneka Corporation.
Check Discount @ www.factmr.com/connectus/sample?flag=D&rep_id=351
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Healthcare Market Research Reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
11140 Rockville Pike
Rockville, MD 20852
Follow us on LinkedIn: www.linkedin.com/company/factmr/
This release was published on openPR.
News-ID: 1086196 • Views: 79More releases